Azora Therapeutics, Inc. (DE)
AZR Nasdaq
SEC CIK 1513525
Follow Azora Therapeutics, Inc. (DE)
Weekly email: filings, results
Net income
−$64.6M
−3498.8% vs same quarter last year
EPS, diluted
−$4.52
−123.8% vs same quarter last year
Operating cash flow
−$6.6M
−261.9% vs same quarter last year
Operating income
−$7.5M
−326.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$7.98T |
| FY24 | −$13.2T |
| FY23 | −$5.12T |
| FY22 | −$12.7M |
| FY21 | −$19.4M |
| FY20 | −$10.9M |
| FY19 | −$8.6M |
| FY18 | −$11.6M |
| FY17 | −$1.1M |
| FY16 | - |